期刊文献+

内皮型一氧化氮合酶在动脉粥样硬化中的作用 被引量:6

暂未订购
导出
出处 《医学研究杂志》 2010年第8期95-97,共3页 Journal of Medical Research
基金 国家"863"项目课题(2008AA02Z425) 国家自然科学基金项目(30670863)
  • 相关文献

参考文献27

  • 1马双陶,陈卫军.血流切应力调控内皮型一氧化氮合酶的分子机制[J].国际生物医学工程杂志,2007,30(4):255-256. 被引量:7
  • 2Hingorani AD,Liang CF,Fatibene J,et al.A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK.Circulation,1999,100:1515-1520.
  • 3Cai H,Wilcken DE,Wang XL.The Glu-298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease.J Mol Med,1999,77:511-514.
  • 4Hibi K,Ishigami T,Tamura K,et al.Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction.Hypertension,1998,32:521-526.
  • 5Markus HS,Ruigrok Y,Ali N,et al.Endothelial nitric oxide synthase exon 7 polymorphism,ischemic cerebrovascular disease,and carotid atheroma.Stroke,1998,29:1908-1911.
  • 6McNamara DM,Holubkov R,Postava L,et al.Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure.Circulation,2003,107:1598-1602.
  • 7Cattaruzza M,Guzik TJ,Slodowski W,et al.Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease.Circ Res,2004,95:841-847.
  • 8Alvarez R,Gomalez P,Batalla A,et al.Association between the NOS3 ((786T/C) and the ACE (I/C) DNA genotypes and early coronary artery disease.Nitric Oxide,2001,5(4):343-348.
  • 9Miyamoto Y,Saito Y,Nakayarna M,et al.Replication protein AI reduces transcription of the endothelial nitric oxide synthase gene containing a T-786C mutation associated with coronary spastic angina.Hum Mol Genet,2000,9(18):2629-2637.
  • 10Oemar BS,Tschudi MR,Godoy N,et al.Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis.Circulation,1998,97:2494-2498.

二级参考文献43

  • 1吕俊萍,马增春,杨静,黄坚,王树人,王升启.Ginsenoside Rg1-induced alterations in gene expression in TNF-α stimulated endothelial cells[J].Chinese Medical Journal,2004(6):871-876. 被引量:4
  • 2Jaffe EA,Nachman RL,Becker CG,et al.Culture of human endothelial cells derived from umbilical veins:identification by morphologic and immunologic criteria[J].J Clin Invest,1973,52 (11):2745-2756.
  • 3R De Caterina,P Libby,HB Peng,et al.Nitric oxide decreases cytokine-induced endothelial activation.Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines[J].J Clin Invest,1995,96(1):60-68.
  • 4Ester WA,Coen AS,Peter H,et al.Protective role of endothelial nitric oxide synthase[J].J Pathol,2003,56(1):8-17.
  • 5Cristina de Assis M,Cristina Plotkowski M,Fierro IM,et al.Expression of inducible nitric oxide synthase in human umbilical vein endothelial cells during primary culture[J].Nitric Oxide,2002,7(4):254-261.
  • 6Suwannaprapha P,Chaisri U,Riyong D,et al.Improvement of function and morphology of tumor necrosis factor-α treated endothelial cells with 17-βestradiol a preliminary study for a feasible simple model for atherosclerosis[J].Circ J,2005,69(6):730-738.
  • 7Yamaoka J,Kabashima K,Kawanishi M,et al.Cytotoxicity of IFN-γ and TNF-α for Vascular Endothelial Cell Is Mediated by Nitric Oxide[J].Biochemical and Biophysical Research Communications,2002,291(4):780-786.
  • 8Morikawa A,Koide N,Kato Y,et al.Augmentation of nitric oxide production by gamma interferonin a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide[J].Infection and Immunity,2000,68(11):6209-6214.
  • 9Galigniana MD,Piwien-Pilipuk G,Assreuy J.Inhibition of glucocorticoid receptor binding by nitric oxide[J].Mol Pharmacol,1999,55(2):317-323.
  • 10Davis ME, Grumbach IM, Fukai T, et al. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor κB binding[J]. J Biol Chem, 2004, 279(1): 163-168.

共引文献10

同被引文献47

  • 1心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:568
  • 2李令华,宋昌稳,黄莉娟,周亚,赵开林,杨成悌,张缤.隐蔽性高血压患者血管活性物质的变化[J].中华高血压杂志,2007,15(9):720-723. 被引量:21
  • 3Tomiyama M,Horio T,Yoshii M,et al.Masked hypertension and target organ damage in treated hypertensive patients[J].Am J Hypertens,2006,19(9):880-886.
  • 4Hulsmans M,Holvoet P.The vicious circle between oxidative stress and inflammation in atherosclerosis[J].J Cell Mol Med,2010,14 (1):70-78.
  • 5Grassi G,Seravalle G,Trevano FQ,et al.Neurogenic abnormalities in masked hypertension[J].Hypertension,2007,50 (3):537-542.
  • 6Pickering TG,DavidsonK,GerinW,et al.Masked Hypertension[J].Hypertension,2002,40 (6):795-796.
  • 7Sega R,Trocino G,Lanzarotti A,et al.Alterations of cardiac structure inpatients with isolated office,ambulatory,or home hypertension:data from the general population (Pressione Arteriose Monitorate E Loro Associazioni[PAMELA] Study)[J].Circulation,2001,104:1385-1392.
  • 8Ohkubo T,Kikuya M,Metoki H,et al.Prognosis of "masked hypertension" and "white-coat " hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study[J].J Am Coll Cardiol,2005,46(3):L508-L515.
  • 9Matsui Y,Eguchi K,Ishikawa J,et al.Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement[J].Am J Hypertens,2007,20(4):385-391.
  • 10Papadopoulos DP,Makris TK,PapazachouU,et al.A ntiendothelial cell antibody levels in patients with masked hypertension[J].Int J Cardio1,2008,130 (3):405-408.

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部